Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-09-12
2006-09-12
Kaushal, Sumesh (Department: 1633)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023400, C435S006120, C435S069100, C435S320100, C435S325000, C435S455000
Reexamination Certificate
active
07105652
ABSTRACT:
A novel human progestin-regulated gene designated EDD (E3 isolated byDifferentialDisplay) is disclosed which encodes a product exhibiting significant amino acid sequence identity with the HYD protein (hyperplastic discs) fromDrosophila melanogasterand the 100 kDa HECT (homologous toE6-APcarboxylterminus) domain protein from rat. The EDD gene appears to represent a tumour suppressor gene and the detection of a polymorphism or alteration in the gene from a subject may be useful for the diagnosis or determination of a predisposition to hyperproliferative disease such as a cancer. An assay for assessing progestin-responsiveness in a subject is also disclosed.
REFERENCES:
patent: 9715674 (1997-05-01), None
Wan et al. Molecular Endocrinology 16:1204-1214, 2002.
Henderson, J. Biological Chemistry, vol. 277, No. 29, pp. 26468-26478, 2002.
Ngo et al., in The protein Folding problem and -tertiary Structure prediction, 1994, Merz et al., (ed.), Birkhauser, Boston, MA, pp. 432-506, 1994.
Yamao, F, J. of Biochemistry, vol. 125, 2:223-229, Feb. 1999.
Clancy et al. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene.22(32):5070-81, 2003.
Rudinger J in Peptide Hormones. Editor Parsons JA. pp. 1-7, 1976, Unversity Park Press, Baltimore.
Wolff RK (Drug Development Research 41:129-141, 1997.
Muller et al (Accession No. X64411.1, database GenEmbl, Oct. 23, 1992.
Callaghan MJ et al. Oncogene 17:3479-3491, 1998.
Cameron ER. Molecular Biotechnology 7:253-265, 1997.
Mullins JJ et al. Hypertension 22:630-633, 1993.
Callaghan et al., “EDD(M-19):Product SC-9562”, Santa Cruz Biotechnology, Inc. (Apr. 2001).
Callaghan et al., “EDD(N-19):Product SC-9561”, Santa Cruz Biotechnology, Inc. (Apr. 2001).
Huibregtse et al., “The Large Subunit of RNA Polymerase II is A substrate of the Rsp5 Ubiquitin-Protein Ligase”, Proc. Natl Acad Sci. 94: 3656-3661 (1997).
Hatakeyama et al., “Subcellular Localization and Ubiquitin-Conjugating Enzyme(E2)Interactions of Mammalian HECT Family Ubiquitin Protein Ligases”, The Journal of Biol. Chemistry vol. 272: 15805-15092 (1997).
Müller et al,Nucleic Acids Research, 20:7, pp. 1471-1475 (1992).
Mansfield et al.,Developmental Biology, 165, pp. 507-526 (1994).
Jon M. Huibretgtse et al., “A Family of Proteins Structurally and Functionally Related to the E6-AP Ubiquitin-Protein Ligase” Proc. Natl Acad Sci vol. 92, pp. 2563-2567 (Mar. 1995).
Callaghan Michelle J.
Sutherland Robert L.
Watts Colin K.
Bozicevic Field & Francis LLP
Francis Carol L.
Garvan Institute of Medical Research
Kaushal Sumesh
LandOfFree
Human tumor suppressor gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tumor suppressor gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tumor suppressor gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585143